Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Looking for somatic mutations in .

Leukemia & lymphoma

Dupuy H, Dussiau C, Bidet A, Sauvezie M, De-Grande AC, Decombe J, Rivière É, Forcade E, Bonnet F, Dumas PY, Duffau P, Pigneux A, Viallard JF, Lazaro E, Dimicoli-Salazar S.
PMID: 34474632
Leuk Lymphoma. 2021 Sep 03;1-3. doi: 10.1080/10428194.2021.1973674. Epub 2021 Sep 03.

No abstract available.

Cite
Dupuy H, Dussiau C, Bidet A, et al. Looking for somatic mutations in . Leuk Lymphoma. 2021;1-3doi: 10.1080/10428194.2021.1973674.
Dupuy, H., Dussiau, C., Bidet, A., Sauvezie, M., De-Grande, A. C., Decombe, J., Rivière, �. �., Forcade, E., Bonnet, F., Dumas, P. Y., Duffau, P., Pigneux, A., Viallard, J. F., Lazaro, E., & Dimicoli-Salazar, S. (2021). Looking for somatic mutations in . Leukemia & lymphoma, 1-3. https://doi.org/10.1080/10428194.2021.1973674
Dupuy, Henry, et al. "Looking for somatic mutations in ." Leukemia & lymphoma vol. (2021): 1-3. doi: https://doi.org/10.1080/10428194.2021.1973674
Dupuy H, Dussiau C, Bidet A, Sauvezie M, De-Grande AC, Decombe J, Rivière É, Forcade E, Bonnet F, Dumas PY, Duffau P, Pigneux A, Viallard JF, Lazaro E, Dimicoli-Salazar S. Looking for somatic mutations in . Leuk Lymphoma. 2021 Sep 03;1-3. doi: 10.1080/10428194.2021.1973674. Epub 2021 Sep 03. PMID: 34474632.
Copy Download .nbib Format: NLM
Looking for somatic mutations in .

Leukemia & lymphoma

Dupuy H, Dussiau C, Bidet A, Sauvezie M, De-Grande AC, Decombe J, Rivière É, Forcade E, Bonnet F, Dumas PY, Duffau P, Pigneux A, Viallard JF, Lazaro E, Dimicoli-Salazar S.
PMID: 34474632
Leuk Lymphoma. 2022 Jan;63(1):250-252. doi: 10.1080/10428194.2021.1973674. Epub 2021 Sep 03.

No abstract available.

Cite
Dupuy H, Dussiau C, Bidet A, et al. Looking for somatic mutations in . Leuk Lymphoma. 2021;63(1):250-252doi: 10.1080/10428194.2021.1973674.
Dupuy, H., Dussiau, C., Bidet, A., Sauvezie, M., De-Grande, A. C., Decombe, J., Rivière, �. �., Forcade, E., Bonnet, F., Dumas, P. Y., Duffau, P., Pigneux, A., Viallard, J. F., Lazaro, E., & Dimicoli-Salazar, S. (2022). Looking for somatic mutations in . Leukemia & lymphoma, 63(1), 250-252. https://doi.org/10.1080/10428194.2021.1973674
Dupuy, Henry, et al. "Looking for somatic mutations in ." Leukemia & lymphoma vol. 63,1 (2022): 250-252. doi: https://doi.org/10.1080/10428194.2021.1973674
Dupuy H, Dussiau C, Bidet A, Sauvezie M, De-Grande AC, Decombe J, Rivière É, Forcade E, Bonnet F, Dumas PY, Duffau P, Pigneux A, Viallard JF, Lazaro E, Dimicoli-Salazar S. Looking for somatic mutations in . Leuk Lymphoma. 2022 Jan;63(1):250-252. doi: 10.1080/10428194.2021.1973674. Epub 2021 Sep 03. PMID: 34474632.
Copy Download .nbib Format: NLM
Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia.

Oncotarget

Dumas PY, Bertoli S, Bérard E, Médiavilla C, Yon E, Tavitian S, Leguay T, Huguet F, Forcade E, Milpied N, Sarry A, Sauvezie M, Bories P, Pigneux A, Récher C.
PMID: 29108292
Oncotarget. 2017 Mar 07;8(45):79126-79136. doi: 10.18632/oncotarget.15988. eCollection 2017 Oct 03.

The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We compared 92 and 107 patients treated, respectively, with intensive chemotherapy or azacitidine within two...

Cite
Dumas PY, Bertoli S, Bérard E, et al. Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia. Oncotarget. 2017;8(45):79126-79136doi: 10.18632/oncotarget.15988.
Dumas, P. Y., Bertoli, S., Bérard, E., Médiavilla, C., Yon, E., Tavitian, S., Leguay, T., Huguet, F., Forcade, E., Milpied, N., Sarry, A., Sauvezie, M., Bories, P., Pigneux, A., & Récher, C. (2017). Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia. Oncotarget, 8(45), 79126-79136. https://doi.org/10.18632/oncotarget.15988
Dumas, Pierre-Yves, et al. "Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia." Oncotarget vol. 8,45 (2017): 79126-79136. doi: https://doi.org/10.18632/oncotarget.15988
Dumas PY, Bertoli S, Bérard E, Médiavilla C, Yon E, Tavitian S, Leguay T, Huguet F, Forcade E, Milpied N, Sarry A, Sauvezie M, Bories P, Pigneux A, Récher C. Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia. Oncotarget. 2017 Mar 07;8(45):79126-79136. doi: 10.18632/oncotarget.15988. eCollection 2017 Oct 03. PMID: 29108292; PMCID: PMC5668025.
Copy Download .nbib Format: NLM
Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis.

Journal of hematology

Mottal N, Issa N, Dumas PY, Camou F, Sauvezie M, Gros FX, Cazaubiel T, Mourissoux G, Leroy H, Pigneux A, Guisset O, Leguay T.
PMID: 33224390
J Hematol. 2020 Dec;9(4):109-115. doi: 10.14740/jh691. Epub 2020 Oct 01.

BACKGROUND: Patients presenting with acute myeloid leukemia (AML) at diagnosis are at high risk of severe complications and death, particularly with high white blood cell (WBC) count. In this retrospective study, we evaluate interest of early and systematic support...

Cite
Mottal N, Issa N, Dumas PY, et al. Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis. J Hematol. 2020;9(4):109-115doi: 10.14740/jh691.
Mottal, N., Issa, N., Dumas, P. Y., Camou, F., Sauvezie, M., Gros, F. X., Cazaubiel, T., Mourissoux, G., Leroy, H., Pigneux, A., Guisset, O., & Leguay, T. (2020). Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis. Journal of hematology, 9(4), 109-115. https://doi.org/10.14740/jh691
Mottal, Nathan, et al. "Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis." Journal of hematology vol. 9,4 (2020): 109-115. doi: https://doi.org/10.14740/jh691
Mottal N, Issa N, Dumas PY, Camou F, Sauvezie M, Gros FX, Cazaubiel T, Mourissoux G, Leroy H, Pigneux A, Guisset O, Leguay T. Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis. J Hematol. 2020 Dec;9(4):109-115. doi: 10.14740/jh691. Epub 2020 Oct 01. PMID: 33224390; PMCID: PMC7665861.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries